CL
CLOV.US Clover Health Investments Corp
- Market cap
- USD 2.66B
- P/E
- 496.0x
- P/B
- 6.68x
- ROE
- 21.1%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is CLOV.US undervalued?
Graham numberThe Graham number of Clover Health Investments Corp cannot be estimated reliably (the estimate is too far from the market price).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Clover Health Investments Corp fundamental analysis
No fundamental analysis for Clover Health Investments Corp yet.
Clover Health Investments Corp stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Clover Health Investments Corp
Clover Health Investments, Corp. provides medicare advantage plans in the United States. The company offers preferred provider organization and health maintenance organization plans to medicare-eligible individuals. It also operates Clover Assistant, a software platform for physicians to detect, identify, and manage chronic diseases. The company was founded in 2014 and is based in Wilmington, Delaware.
Full company profileClover Health Investments Corp financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Clover Health Investments Corp annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||
| Revenue | 281M | 462M | 673M | 1.47B | 1.10B | 1.26B | 1.37B | 1.92B | 3.00B |
| Gross Profit | 281M | 12.6M | 82.8M | -79.2M | 103M | 256M | 365M | 356M | 590M |
| Operating Income | -186M | -183M | -92.7M | -637M | -287M | -205M | -45.7M | -85.5M | 82.4M |
| EBITDA | -372M | -324M | -78.7M | -570M | -252M | -208M | -44.9M | -83.9M | 84.6M |
| Net Income | -202M | -364M | -136M | -588M | -340M | -213M | -43.0M | -85.5M | 82.4M |
| EPS | -4.81 | -0.90 | -0.34 | -1.25 | -0.71 | -0.44 | -0.09 | -0.17 | 0.15 |
| Balance Sheet | |||||||||
| Total Assets | 211M | 100K | 267M | 951M | 809M | 571M | 581M | 541M | 754M |
| Total Liabilities | 265M | 118K | 880M | 411M | 452M | 284M | 240M | 232M | 363M |
| Shareholders' Equity | -54.8M | -17.6K | -617M | 535M | 357M | 286M | 341M | 309M | 391M |
| Cash & Short-term Investments | 75.4M | 67.6M | 96.7M | 615M | 335M | 236M | 222M | 95.3M | 273M |
| Total Debt | 49.3M | 57.9M | 138M | 27.8M | 5.86M | 4.66M | - | - | - |
| Cash Flow | |||||||||
| Operating Cash Flow | -153M | -160M | -118M | -282M | -204M | -116M | 34.8M | -66.9M | 271M |
| Capital Expenditure | 1.48M | 23.0K | 693K | 723K | 4.47M | 584K | 1.56M | 2.04M | 3.25M |
| Free Cash Flow | -155M | -160M | -119M | -283M | -208M | -116M | 33.3M | -69.0M | 268M |
| Ratios | |||||||||
| ROE | - | - | - | -109.8% | -95.1% | -74.5% | -12.6% | -27.7% | 21.1% |
| ROA | -95.9% | -362,482.8% | -51.0% | -61.8% | -42.0% | -37.4% | -7.4% | -15.8% | 10.9% |
| Net Profit Margin | -71.9% | -78.7% | -20.3% | -39.9% | -31.0% | -16.9% | -3.1% | -4.4% | 2.7% |
| Debt to Equity | - | - | - | 0.05x | 0.02x | 0.02x | - | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Clover Health Investments Corp dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- -
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | - | - | - |
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | - | - | - |
| 2021 | USD 305K | 0.00 | - |
| 2020 | USD 957K | 0.00 | - |
| 2019 | - | - | - |
| 2018 | - | - | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Clover Health Investments Corp
- Insiders 4.26%
- Institutions 34.48%
- Public & others 61.26%
- Shares outstanding 440M
- Free float 417M
Top funds holding CLOV.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| Vanguard MStar Total Stk Mkt Idx Invest | 13.1M | 2.45% | +0.36% | Sep 2026 |
| iShares Russell 2000 ETF | 10.6M | 1.99% | 0.00% | Oct 2026 |
| Fidelity Small Cap Index | 4.61M | 0.86% | +0.15% | Aug 2026 |
| iShares Russell 2000 Growth ETF | 3.94M | 0.74% | -0.38% | Oct 2026 |
| Nuveen Quant Small Cap Equity R6 | 2.58M | 0.48% | +44.83% | Aug 2026 |
| Vanguard Russell 2000 ETF | 2.45M | 0.46% | +1.16% | Sep 2026 |
| Schwab US Small-Cap ETF™ | 2.30M | 0.43% | +0.24% | Oct 2026 |
| Fidelity Extended Market Index | 2.01M | 0.38% | +1.49% | Sep 2026 |
| First Trust Small Cap Gr AlphaDEX® ETF | 1.99M | 0.37% | +0.43% | Oct 2026 |
| CREF Total Global Stock Account R3 | 1.82M | 0.34% | +0.56% | Aug 2026 |
| Nuveen Quant Small/Mid Cap Eq R6 | 1.72M | 0.32% | +16.68% | Aug 2026 |
| Schwab Fundamental U.S. Small CompanyETF | 1.62M | 0.30% | 0.00% | Oct 2026 |
| Vanguard Strategic Equity Inv | 1.26M | 0.24% | +368.34% | Sep 2026 |
| Vanguard Health Care ETF | 1.25M | 0.24% | +0.11% | Sep 2026 |
| BlackRock Advantage Small Cap Core Instl | 1.10M | 0.21% | +3.47% | Sep 2026 |
| Schwab Small Cap Index | 1.02M | 0.19% | -0.86% | Sep 2026 |
| First Trust Small Cap Core AlphaDEX® ETF | 979K | 0.18% | 0.00% | Oct 2026 |
| DFA US Micro Cap I | 962K | 0.18% | +2.58% | Sep 2026 |
| DFA U.S. Small Cap I | 930K | 0.17% | +1.01% | Sep 2026 |
| Stt Strt® SPDR® S&P®HlthCrSvcsETF | 886K | 0.17% | 0.00% | Oct 2026 |
Top institutions holding CLOV.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| BlackRock Inc | 35.1M | 6.58% | +10.26% | Jun 2026 |
| Vanguard Capital Management, LLC | 18.0M | 3.38% | +6.22% | Jun 2026 |
| Geode Capital Management, LLC | 10.8M | 2.03% | +7.86% | Jun 2026 |
| State Street Corp | 10.2M | 1.91% | +6.49% | Jun 2026 |
| Nuveen, LLC | 6.29M | 1.18% | +572.52% | Jun 2026 |
| Charles Schwab Investment Management Inc | 5.52M | 1.04% | +4.16% | Jun 2026 |
| Vanguard Portfolio Management, LLC | 4.47M | 0.84% | +20.94% | Jun 2026 |
| Northern Trust Corp | 3.77M | 0.71% | +14.09% | Jun 2026 |
| PNC Financial Services Group Inc | 3.56M | 0.67% | -5.32% | Jun 2026 |
| Dimensional Fund Advisors, Inc. | 3.37M | 0.63% | +7.07% | Sep 2026 |
| Vanguard Fiduciary Trust Co | 2.92M | 0.55% | +4.05% | Jun 2026 |
| Renaissance Technologies Corp | 2.81M | 0.53% | -17.47% | Jun 2026 |
| Morgan Stanley - Brokerage Accounts | 2.29M | 0.43% | +4.93% | Jun 2026 |
| Citadel Advisors Llc | 2.16M | 0.41% | +15.18% | Jun 2026 |
| D. E. Shaw & Co LP | 1.97M | 0.37% | +2,059.62% | Jun 2026 |
| Marshall Wace Asset Management Ltd | 1.56M | 0.29% | 0.00% | Jun 2026 |
| Amvescap Plc. | 1.34M | 0.25% | +29.99% | Jun 2026 |
| GMT Capital Corp | 1.31M | 0.24% | 0.00% | Jun 2026 |
| Mackenzie Investments | 1.30M | 0.24% | 0.00% | Jun 2026 |
| Jane Street Group LLC | 1.29M | 0.24% | +24.01% | Jun 2026 |
Clover Health Investments Corp company profile
- Company name
- Clover Health Investments Corp
- Ticker
- CLOV.US
- Exchange
- USA Stocks
- Listed since
- Jan 2, 2001
- Sector
- Healthcare
- Industry
- Health Care Providers & Services
- Employees
- 724
- Fiscal year end
- December
- Address
- 1209 Orange Street, Wilmington, DE, United States, 19801
- Phone
- 201 432 2133
- Website
- cloverhealth.com
About Clover Health Investments Corp
Clover Health Investments, Corp. provides medicare advantage plans in the United States. The company offers preferred provider organization and health maintenance organization plans to medicare-eligible individuals. It also operates Clover Assistant, a software platform for physicians to detect, identify, and manage chronic diseases. The company was founded in 2014 and is based in Wilmington, Delaware.
Clover Health Investments Corp management
10- Mr. Vivek GaripalliCo-Founder & Executive Chairman · born 1979
- Mr. Andrew ToyCo-Founder, CEO & Director · born 1979
- Ms. Jamie L. ReynosoChief Executive Officer of Medicare Advantage · born 1969
- Mr. Conrad WaiCEO of Counterpart Health · born 1981
- Mr. Joseph Clay ThorntonCFO & Principal Financial Officer · born 1990
- Mr. Joseph Frank OldakowskiVP of Finance, Controller, Principal Accounting Officer & Chief Accounting Officer · born 1983
- Ms. Wendy RicheyChief Compliance Officer
- Ms. Karen SoaresChief Legal Officer, General Counsel, Senior VP & Corporate Secretary · born 1978
- Ms. Rachel FishChief People Officer
- Dr. Kumar DharmarajanChief Medical Officer of Clover Assistant · born 1980